Publications found:
51,015
Sort by:
US Blood Banking Market: Innovative Technologies and Emerging Business Opportunities
US$ 7,120.00
This report contains 460 pages, 53 tables and presents a comprehensive analysis of the US blood banking market, including: Major issues pertaining to the US ... key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Specifically, the study ...
December 2012
460 pages
Analyzing the Natural Gas Industry in the US
US$ 450.00
... globally. Aruvian Research’s report – Analyzing the Natural Gas Industry in United States - analyzes the scope of American natural gas production and consumption. In view of understanding natural gas transactions, the report studies ...
December 2012
160 pages
Brisotl-Myers Squibb - Eliquis Approved for SPAF in Europe – Waiting for decision with FDA
US$ 90.00
... and PFE announced the long awaited approval of Eliquis for stroke prevention in atrial fibrillation ... US approval, for which the PDUFA data has been set for 17th March 2013. . We foresee Eliquis clearly ... demonstrated in the ROCKET-AF trial. We expect Eliquis to cannibalize Pradaxa sales initially, while extensive ...
November 2012
2 pages
Celgene - ABRAXANE + Pipeline Drugs = Long Term Growth!
US$ 140.00
... Revlimid’s label expansion in 1st line RRMM and as maintenance therapy in EU, Celgene (CELG) 3Q12 earnings highlighted growth of Revlimid globally on both a YoY ... data from ABRAXANE trials in melanoma and pancreatic cancer……please read our report released on 11th Nov. 2012, titled, 'ABRAXANE + Pipeline Drugs = ...
November 2012
7 pages
AMGEN- Launched Products + Geographical Expansion Should Sustain the Growth Momentum
US$ 140.00
... Biosimilars opportunity. AMGN is trading below the NPV of its marketed products + net debt ($92.0/s) and in light of upcoming catalysts, we ... more details on pipeline products, please read our report released on 8th Nov. 2012, titled, “Amgen - Launched Products + Geographical Expansion Should Sustain the ...
November 2012
7 pages
BIOGEN IDEC - Diversification and Strong Foothold in MS to Reign
US$ 90.00
We continue to like Biogen Idec (BIIB) as next year is also going to be eventful: Approval and launch of BG-12 ( ... , please read our report released on 7th Nov. 2012, titled, “Biogen Idec - Diversification and Strong Foothold in MS to Reign”.
November 2012
4 pages
PFIZER, Xeljanz (tofacitinib) approved for RA, but we see limited potential
US$ 90.00
Pfizer has been granted FDA approval for Xeljanz (tofacitinib) 5 mg twice daily for the ... fortnightly (subcutaneous) or much less frequent than tofacitinib. Besides no differentiation from a clinical perspective ... alpha therapy. Pfizer is also planning to discuss with FDA for the role of tofacitinib as first-line ...
November 2012
2 pages
US Prenatal Testing Market Report: 2012 Edition
US$ 800.00
... posing acute challenges. This report provides a comprehensive overview of the US prenatal testing market covering the market opportunity for the T21 tests. The prenatal testing realm is getting intensely ...
October 2012
42 pages
Gilead - Life Cycle Management For Hiv And Hcv Pipeline = Upside
US$ 140.00
... Subject: GILEAD – Life Cycle Management for HIV and HCV Pipeline = Upside Abstract 3Q12 earnings (Table 1) and revised upward revenue guidance validates Gilead’s (GILD ... , please read our report released on 1st Nov., 2012, titled, “Life Cycle Management for HIV and HCV Pipeline = Upside”. Report type – Deep ...
October 2012
7 pages
Alexion - Innovative Drugs For Orphan Diseases Focus = Stability!
US$ 140.00
Abstract Alexion (ALXN) products lack any near term competition ... products beyond Soliris. The fall in the stock price of Alexion (ALXN) despite robust 3Q12 earnings presents a long term buying ... read our report released on 31st September, 2012, titled, “ Innovative Drugs for Orphan Diseases Focus = Stability!”
October 2012
5 pages
UnitedHealth Group, Inc. - 2012 Corporate Analysis
US$ 400.00
... as well as health care resource organization and care facilitation. The Group has leveraged these capabilities in two broad market areas - ... people as states implement national health care reforms in the next decade. UnitedHealth faces stiff competition from companies like WellPoint, Inc., Aetna Inc., Cigna ...
October 2012
33 pages
The US Specialty Pharmaceutical Market Report: 2012 Edition
US$ 800.00
... which fall within the bounds of specialty pharmaceuticals. There is no particular definition for specialty pharmaceutical but on the basis of some ... overview of the US specialty pharmaceutical market covering various disease segments and the specialty pharmacy market. The specialty pharma realm is intensely ...
September 2012
65 pages
BIOGEN IDEC - “Refuse to File Letter” to Lemtrada = Modest Positive for BIIB
US$ 90.00
... , RRMS) by at least 6 months or more will be perceived as a modest positive for Biogen Idec (BIIB) which should continue to dominate the MS space. BIIB has ... read our report released on 27th August, 2012 on BIIB titled, “Refuse to File Letter" to Lemtrada = Modest Positive for BIIB”.
August 2012
2 pages
Onyx pharma - In the Driver’s Seat, with Kyprolis Approval
US$ 90.00
... the setback to Brivanib (BMS, HCC) have swung the wind in Onyx’s (ONXX) favor. Kyprolis has the first mover advantage in catering ... detail, please read our report released on 9th Aug. 2012, on Onyx Pharma titled “In the Driver’s Seat, with Kyprolis Approval”.
August 2012
3 pages
Celgene - Waiting for More Positives...
US$ 140.00
Celgene’s (CELG) 2Q12 results lifted the gloom around news related to ... and EU by YE12 / in early 1Q13). However, … For more detail, please read our report released on 3rd Aug, 2012, titled, “Waiting for More Positives…”
August 2012
3 pages
State of the Industry: Art Dealers in the U.S.
US$ 149.00
Note: Formats of Delivery: Word and ExcelPDF upon request State of the Industry reports are concise, yet detailed studies filled with priceless data, forecasts, and objective analysis. The amount of...
August 2012
-
State of the Industry: Sporting Goods Stores in the U.S.
US$ 149.00
Note: Formats of Delivery: Word and ExcelPDF upon request State of the Industry reports are concise, yet detailed studies filled with priceless data, forecasts, and objective analysis. The amount of...
August 2012
-
Analyzing the US Magnesium Industry
US$ 400.00
... alloying agent to make aluminum-magnesium alloys, sometimes called 'magnalium' or 'magnelium'. Magnesium compounds, primarily magnesium oxide, are used mainly as ... - Analyzing the US Magnesium Industry. The report looks at the basics of magnesium, the global magnesium industry, and the US magnesium industry. ...
August 2012
55 pages
Analyzing the Hair Care Market in the US
US$ 300.00
... hair care market in the United States. The report begins with an analysis of the basics of hair care and then moves on to analyze the hair care industry in the US. The report analyzes the market segmentation, market ...
August 2012
60 pages
Analyzing the US Biomass & Biofuels Industry
US$ 450.00
The United States has been advocating the growth of biomass and biofuels as a clean source of fuel for the transportation industry. In a ... and biofuels. Aruvians Rsearch in its report Analyzing the US Biomass and Biofuels Industry analyzes the US biomass power market and the biofuels market in the ...
August 2012
120 pages
Analyzing the Market for Athletic Footwear in the US
US$ 400.00
... the athletic footwear industry in the United States was not left impervious from the ill-effects of recession. The market demand ... rest of us to work. Aruvians Rsearch analyzes the athletic footwear market in the US in its research offering Analyzing the Market for Athletic Footwear in the US. The report is ...
August 2012
75 pages
Analyzing the Market for Synthetic Rubber in the US
US$ 450.00
... products made of synthetic rubber have long been in demand. However, the synthetic rubber industry in the United States encountered a slump in ... -based feedstock. Aruvians Rsearch analyzes the synthetic rubber market in the US in its research offering Analyzing the Market for Synthetic Rubber in the US. The ...
August 2012
100 pages
Analyzing the Reinforced Plastics Market in the US
US$ 450.00
... processors, to manufacturers of finished products. Aruvians Rsearch analyzes the reinforced plastics market in the US in its research offering Analyzing the Reinforced Plastics Market in the US. The report is a complete analysis of the ...
August 2012
100 pages
